Xtl Biopharmaceuticals (XTLB) EPS (Diluted) Growth (1y) (2010 - 2024)
Xtl Biopharmaceuticals (XTLB) EPS (Diluted) Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 36.94% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,091.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.58% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.16% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 96.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -261.32% |
| Sep 30, 2024 | 103.48% |
| Jun 30, 2024 | -93.41% |
| Mar 31, 2024 | 152.78% |
| Dec 31, 2023 | 13.35% |
| Sep 30, 2023 | 555.65% |
| Jun 30, 2023 | -27.72% |
| Mar 31, 2023 | -1,395.41% |
| Dec 31, 2022 | -670.65% |
| Sep 30, 2022 | 75.25% |
| Jun 30, 2022 | -124.00% |
| Mar 31, 2022 | -76.00% |
| Dec 31, 2021 | -9,397,848.12% |
| Sep 30, 2021 | -16,854,439.66% |
| Jun 30, 2021 | 112,039,136.00% |
| Dec 31, 2020 | 100.00% |
| Sep 30, 2020 | -96.25% |
| Jun 30, 2020 | 113.08% |
| Dec 31, 2019 | 41.59% |
| Sep 30, 2019 | -200.00% |